Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility 36th Annual Meeting of the Association-of-VA-Surgeons Bakaeen, F. G., Kar, B., Chu, D., Cornwell, L. D., Blaustein, A., Levine, G. N., Paniagua, D., Jneid, H., Jensen, C., Atluri, P. V., Bechara, C. F., Kougias, P., Pawlak, C., Bozkurt, B., Burdon, T. A., Carabello, B. A. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC. 2012: 643–48

Abstract

The US Food and Drug Administration recently approved a transcatheter aortic valve for patients for whom open heart surgery is prohibitively risky.A multidisciplinary heart valve team partnered with administration to launch a transcatheter aortic valve replacement (TAVR) program. Clinical registries were used to show robust valve caseloads and outcomes at our Veterans Affairs (VA) facility and to project future volumes. A TAVR business plan was approved by the VA leadership as part of a multiphase project to upgrade and expand our surgical facilities.The heart valve team completed a training program that included simulations and visits to established TAVR centers. Patients were evaluated and screened through a streamlined process, and the program was initiated successfully.Establishing a TAVR program at a VA facility requires a multidisciplinary team with experience in heart valve and endovascular therapies and a supportive administration willing to invest in a sophisticated infrastructure.

View details for DOI 10.1016/j.amjsurg.2012.07.017

View details for Web of Science ID 000311734000022

View details for PubMedID 22921150